Open Access
Issue
BIO Web Conf.
Volume 121, 2024
Global Summit on Life Sciences and Bio-Innovation: From Agriculture to Biomedicine (GLSBIA 2024)
Article Number 04005
Number of page(s) 6
Section Frontiers in Genetics and Microbiological Research
DOI https://doi.org/10.1051/bioconf/202412104005
Published online 22 July 2024
  • L. Z. Alekesheva, M. A. Abdullaeva, A. S. Inoyatov, O. I. Jabborova, M. A. Nigmatullaeva, M. O. Kudratova, U. O. Navruzova, Annals of the Romanian Society for Cell Biology 25(4), 1873-1880 (2021) [Google Scholar]
  • Z. Z. Aminov, S. Z. Khakimova, S. S. Davlatov, European Journal of Molecular & Clinical Medicine 7(3), 2540-2545 (2020) [Google Scholar]
  • A. K. Ashirmetov, I. R. Mavlyanov, Z. I. Mavlyanov, G. Z. Zharylkasynova, Health Risk Analysis 4 (2020) [Google Scholar]
  • S. Davlatov, K. Rakhmanov, N. Qurbonov, I. Vafayeva, D. Abduraxmanov, International Journal of Pharmaceutical Research 12, 1931-1939 (2020) [Google Scholar]
  • O. E. Idiev, S. Z. Teshaev, Journal of Pharmaceutical Negative Results 13 (2022) [Google Scholar]
  • G. A. Ikhtiyarova, N. K. Dustova, M. A. Khasanova, G. S. Suleymanova, S. S. Davlatov, International Journal of Pharmaceutical Research 13(1), 1935-1942 (2021) [Google Scholar]
  • G. A. Ikhtiyarova, N. K. Dustova, M. A. Khasanova, G. S. Suleymanova, S. S. Davlatov, International Journal of Pharmaceutical Research 13(1), 1935-1942 (2021) [Google Scholar]
  • F. U. Jabborova, Journal of Pharmaceutical Negative Results 13 (2022) [Google Scholar]
  • F. U. Jabborova, Journal of Pharmaceutical Negative Results 13 (2022) [Google Scholar]
  • F. U. Jabborova, Journal of Pharmaceutical Negative Results 13 (2022) [Google Scholar]
  • M. K. Kamalova, I. V. Fomenko, D. S. Dmitrienko, N. V. Matvienko, E. N. Arjenovskaya, A. G. Gevorkyan, E. E. Maslak, European Journal of Molecular and Clinical Medicine 7(7), 546-558 (2020) [Google Scholar]
  • F. E. Nurbaev, Yu. S. Khamraeva, “Pharmacogenomic analysis of costs for the treatment of chronic hepatitis “B” in hospital (Retrospective study)”, in New day in medicine (2017) [Google Scholar]
  • F. E. Nurbaev, B. Z. Dzhumaev, “Ways to improve the pharmacoeconomic efficiency of therapy in intrahepatic syndrome”, in New day in medicine (2017) [Google Scholar]
  • F. E. Nurbaev, B. Z. Dzhumaev “Optimization of chronic pharmacotherapy of chronic diffuse liver diseases with the predominance of cholestasis syndrome”, in New day in medicine (2018) [Google Scholar]
  • A. R. Oblokulov, G. E. Niyozov, International Journal of Pharmaceutical Research 12(4), 3749-3752 (2020) [Google Scholar]
  • A. R. Oblokulov, Z. Z. Husenova, M. M. Ergashev, Annals of the Romanian Society for Cell Biology 25(3), 5220-5224 (2021) [Google Scholar]
  • A. R. Obloqulov, T. D. Yitmasova, S. A. Sanakulova, Journal of Pharmaceutical Negative Results 13 (2022) [Google Scholar]
  • D. K. Rozikova, N. N. Khabibova, Annals of the Romanian Society for Cell Biology 25(1), 6668-6673 (2021) [Google Scholar]
  • M. Urinov, N. Alikulova, D. Zukhritdinova, M. Usmonov, R. Urinov, International Journal of Health Sciences 5(3) (2021) [Google Scholar]
  • M. Urinov, N. Alikulova, D. Zukhritdinova, M. Usmonov, R. Urinov, International Journal of Health Sciences 5(3) (2021) [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.